Main Article Content
Objective: To explore the prevention and control strategies and effects of COVID-19 in People's Hospital of Tongchuan so as to provide evidence for prevention and control of COVID-19 in Tongchuan.
Methods: The measures taken by People's Hospital of Tongchuan from the aspects of sound organization, new coronavirus knowledge training, prevention of nosocomial infection, establishment of elite medical team, scientific and precise treatment and internet application as well as medical treatment were reviewed.
Results: Between 23 January 2020 and 15 April 2020, the hospital had received a total of 6 patients with confirmed COVID-19, among which 3 patients have been discharged. More than 31,000 persons were given pre-examination triage, 2,605 persons were treated for fever at clinics, 596 persons were under isolation and observation, and 184 persons had nucleic acid test, so as to achieve the requirements of no missed diagnosis, no death and no infection goal, which were prioritized by the national, provincial and municipal health inspection teams.
Conclusion: The effective prevention and control strategies against COVID-19 in People’s Hospital of Tongchuan have significantly achieved the "three zeros" goal namely zero infection, zero transmission and zero death.
People's Hospital of Tongchuan, founded in 1949, is a comprehensive level-III first-class hospital. It has two hospitals located in the north and the south, with 1,700 beds and 2,044 employees. It is the first designated hospital for treatment of COVID-19  in the province.
The CoVID-19 Diagnosis and Treatment Protocol, edition 1, National Health Commission. 2020;3.
Covid-19 Prevention and Control Plan (Third edition), National Health Commission. 2020;1(28).
Novel Coronavirus Infection Laboratory Testing Technical Guide (second edition), National Health Commission. 2020;1(23).
The CoVID-19 Diagnosis and Treatment Protocol, edition 6, National Health Commission. 2020;3(7).
Analyzes the developmentt rend of medical industry in the future DaiTao, Boao Forumfor Asia. 2019;6(10).
Zhao Z, Sokhansanj BA, Rosen GL. Characterizing geographical and temporal dynamics of novel coronavirus SARS-CoV-2 using informative subtype markers. Bio Rxiv. 2020:1–32.
SUL, MAX, YUH, et al. The different clinical characteristics of Coronavirus disease cases between childrenand their families in China the character of children with COVID－19 [J]. Emerg Microbes Infect. 2020;9(1):707-713